Roivant Sciences Ltd. (ROIV)
NASDAQ
Closed
Sep 10, 2026
Day's Range
40.2252 wk Range
13.39Overview - ROIV - Roivant Sciences Ltd.
Key Statistics
Valuation
Enterprise Value
26.91B
P/E (Trailing)
‪1.94‬
P/E (Forward)
‪-24.14‬
PEG Ratio
‪-0.09‬
Price / Sales (TTM)
‪3,977.95‬
Price / Book
‪7.08‬
EV / EBITDA
‪-19.78‬
Profitability
Gross Margin
‪80.30%‬
Profit Margin
‪84.44%‬
Operating Margin
‪-25,408.11%‬
Return on Assets
‪-16.48%‬
Return on Equity
‪-8.51%‬
Ownership
Shares Outstanding
722.66M
Float
580.42M
Short % of Shares Outstanding
‪5.58%‬
Held by Insiders
‪21.44%‬
Held by Institutions
‪78.40%‬
Price stats
Beta
‪1.12‬
50-Day Avg
‪35.28‬
200-Day Avg
‪28.49‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪$ 41.95‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ROIV - Roivant Sciences Ltd.
Peers - ROIV - Roivant Sciences Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ROIVNASDAQRoivant Sciences Ltd.30.20BMarket Cap+65.53%52-week change1.95P/E (Trailing)‪84.44%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt64.24BMarket Cap+25.70%52-week change40.24P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.35.60BMarket Cap-70.99%52-week change45.79P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE26.05BMarket Cap-8.41%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S17.75BMarket Cap+23.94%52-week change20.58P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.14.63BMarket Cap+27.46%52-week change-19.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.87BMarket Cap+15.26%52-week change179.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ROIV - Roivant Sciences Ltd.
About
Roivant Sciences Ltd. is an American multinational healthcare company that develops transformative medicines and technologies by creating agile, focused subsidiaries called Vants. These Vants target specific therapeutic areas, including autoimmune diseases through Immunovant, severe autoimmune conditions via Priovant,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
